Neuphoria Therapeutics NEUP
NASDAQ NEUP
$3.95 +0.02 (+0.51%)
At close: Aug 20, 2026 · 4:00 PM EDT

Neuphoria Therapeutics (NEUP) Tax Rate (2023 - 2026)

Neuphoria Therapeutics (NEUP) posted quarterly Tax Rate of 6.44% for Q1 2026, up 717.0% year-over-year from 0.79% in Q1 2025, and up 438.84% quarter-over-quarter from 1.9% in Q4 2025.

Neuphoria Therapeutics (NEUP) Tax Rate (2023 - 2026) Analysis & Trends

Neuphoria Therapeutics (NEUP) has reported Tax Rate for 4 consecutive years, with 6.44% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Tax Rate rose 717.0% year-over-year to 6.44%; the TTM figure through Mar 2026 stood at 0.91% (up 998.0% YoY), while the FY2025 annual figure was 0.0%, down 295.0% from the prior year.
  • Tax Rate rose to 6.44% in Q1 2026 per NEUP's latest filing, from 1.9% in the prior quarter.
  • Across five years, Tax Rate topped out at 14.96% in Q2 2024 and bottomed at 9.9% in Q2 2025.
  • Historically, Tax Rate has averaged 2.14% across 4 years, with a median of 0.35% in 2025.
  • Annual changes were most pronounced in 2024 — Tax Rate soared 1348 bps — and 2025, when it sank 2486 bps.
  • Neuphoria Therapeutics' Tax Rate stood at 0.76% in 2023, then sank by 179 bps to 0.6% in 2024, then sank by 217 bps to 1.9% in 2025, then jumped by 439 bps to 6.44% in 2026.
  • Business Quant data shows NEUP's Tax Rate at 6.44% in Q1 2026, 1.9% in Q4 2025, and 0.35% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 20.98%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 15.11%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 10.91%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1.96%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 24.15%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 7.49%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -16.71%
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 34.12%
10 Neuphoria Therapeutics 21.37 Mn 1.93 Mn - 6.44%

Historic Data

Download Data
DateValue
Mar 31, 2026 6.44%
Mar 31, 2026 6.44%
Mar 31, 2026 6.44%
Dec 31, 2025 -1.90%
Dec 31, 2025 -1.90%
Dec 31, 2025 -1.90%
Sep 30, 2025 0.35%
Sep 30, 2025 0.35%
Sep 30, 2025 0.35%
Jun 30, 2025 -9.90%
Jun 30, 2025 -9.90%
Jun 30, 2025 -9.90%
Mar 31, 2025 -0.73%
Mar 31, 2025 -0.73%
Mar 31, 2025 -0.73%
Dec 31, 2024 -0.60%
Dec 31, 2024 -0.60%
Dec 31, 2024 -0.60%
Sep 30, 2024 14.11%
Sep 30, 2024 14.11%